Skip to main content

Table 2 Baseline characteristics and measurements of lung function

From: Natural history of lung function in spinal muscular atrophy

Patients
SMA typeType 1c
(n = 6)
Type 2a
(n = 48)
Type 2b
(n = 34)
Type 3a
(n = 43)
Type 3b
(n = 35)
Type 4
(n = 4)
M: F3: 319: 2912: 2218: 2518: 174: 0
SMN2 copies
 211111
 354427215
 43521254
 53
 n/a11
Mechanical ventilation: n (% of total)5 (83.3%)23 (47.9%)3 (8.8%)5 (11.6%)b1 (2.9%)b0
Median age at start of mechanical ventilation (IQR)14.6a (13.1–25.9)12.3b (8.2–16.9)16.8 (12.7–20.8)39.9c (35.9–48.3)40.0cn/a
Assessments
Lung function testPatients,n (%)No. of patient assessmentsMedian no. of assessments per patient (range)
FEV1163 (95.9)7845 (1–40)
FVC167 (98.2)6684 (1–32)
VC80 (47.1)6466 (1–38)
  1. Legend: SMA spinal muscular atrophy; n number of patients or assessments; M males, F females, SMN2 survival motor neuron 2 gene, IQR interquartile range; n/a: not available, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, VC vital capacity
  2. a: the high median age at which mechanical ventilation was initiated in patients with SMA type 1c is explained by the fact that in The Netherlands it was uncommon to initiate mechanical ventilation for infants with SMA type 1 until recent years, as it was considered not ethical to prolong life without any realistic outlook for further improvements of motor function at a later time. This has changed in the past years, following the introduction of SMN protein augmenting drugs and current clinical drug trials. b: the exact age at which mechanical ventilation was started is unknown for one patient; c: excluded are two patients with SMA type 3a and one patient with type 3b using either bi-level or continuous positive airway pressure for obstructive sleep apnoea syndrome. Ages are shown in years